课题基金 / 基金详情

BMS 188667 (CTLA4KG) IN PATIENTS WITH PSORIASIS VULGARIS

BMS 188667 (CTLA4KG) IN PATIENTS WITH PSORIASIS VULGARIS
BMS 188667 (CTLA4KG) 用于寻常型银屑病患者
批准号:
6274552
负责人:
CYNTHIA GUZZO
金额:
$2.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-15 至 1998-11-30

项目摘要

项目成果

CYNTHIA GUZZO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
BMS-188667 (CTLA4Ig) represents a new class of agent that targets the blockade of the second signal in T cell activation. It has been studied in man in 3 Phase I protocols with acceptable toxicity and some efficacy in the treatment of psoriasis. This study was designed to assess the biologic activity of chronic intermittent administration of BMS-18667 in patients with psoriasis vulgaris. A major goal was to select the optimum dosing schedule. Three dosage levels (8.0, 16.0, 25.0 mg/kg were administered in 2 dosage schedules.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SAFETY, TOLERABILITY, AND BIOLOGIC ACTIVITY OF L 733,723 IN PSORIATIC PATIENTS
  • 批准号:
    6274493
  • 项目类别:
  • 资助金额:
    $2.5万
  • 财政年份:
    1998
  • 负责人:
    CYNTHIA GUZZO
  • 依托单位:
TOLERABILITY/PHARMACOKINETICS OF DAB389 IL 2 IN PATIENTS WITH SEVERE PSORIASIS
  • 批准号:
    6274518
  • 项目类别:
  • 资助金额:
    $2.5万
  • 财政年份:
    1998
  • 负责人:
    CYNTHIA GUZZO
  • 依托单位:
PHASE I STUDY OF BMS188667 IN PSORIASIS VULGARIS
  • 批准号:
    6274478
  • 项目类别:
  • 资助金额:
    $2.5万
  • 财政年份:
    1998
  • 负责人:
    CYNTHIA GUZZO
  • 依托单位:
DOSE ESCALATION STUDY OF MEDI 507, HUMANIZED MONOCLONAL ANTIBODY CD2
  • 批准号:
    6263605
  • 项目类别:
  • 资助金额:
    $2.51万
  • 财政年份:
    1998
  • 负责人:
    CYNTHIA GUZZO
  • 依托单位:
海外基金